Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 74 of 74 found
From 8 References


Chen et al 2018, Proc Natl Acad Sci U S A
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
PPP4R3A/IGH
t(14;14)(q32;q32)
T-Lineage

Edgren et al 2011, Genome Biol
  Adenocarcinoma Breast
CCDC85C/SETD3
t(14;14)(q32;q32)

Hu et al 2018, Nucleic Acids Res
  Mesenchymal tumor, NOS Unknown site
ATG2B/TDRD9
t(14;14)(q32;q32)
  Transitional cell carcinoma Bladder
CCDC88C/C14orf159
t(14;14)(q32;q32)
  Adenocarcinoma Breast
CDC42BPB/UNC79
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
CDCA4/C14orf79
t(14;14)(q32;q32)
  Transitional cell carcinoma Bladder
CLMN/WDR20
t(14;14)(q32;q32)
  Adenocarcinoma Adrenal
CRIP2/MTA1
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
DICER1/PAPOLA
t(14;14)(q32;q32)
  Adenocarcinoma Stomach
DICER1/CLMN
t(14;14)(q32;q32)
  Adenocarcinoma Prostate
DYNC1H1/EVL
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
DYNC1H1/EIF5
t(14;14)(q32;q32)
  Adenocarcinoma Liver
EFCAB11/C14orf180
t(14;14)(q32;q32)
  Mesenchymal tumor, NOS Unknown site
HHIPL1/CCNK
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
HSP90AA1/MOK
t(14;14)(q32;q32)
  Astrocytoma, grade I-II Brain
KCNK13/TDP1
t(14;14)(q32;q32)
  Adenocarcinoma Stomach
KIF26A/C14orf2
t(14;14)(q32;q32)
  Adenocarcinoma Uterus, corpus
KLC1/MARK3
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
MARK3/EIF5
t(14;14)(q32;q32)
  Adenocarcinoma Lung
MOK/CINP
t(14;14)(q32;q32)
  Transitional cell carcinoma Bladder
NRDE2/CATSPERB
t(14;14)(q32;q32)
  Adenocarcinoma Uterus, corpus
PAPOLA/GSKIP
t(14;14)(q32;q32)
  Adenocarcinoma Stomach
PPP2R5C/FOXN3
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
RIN3/CCDC88C
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
RPS6KA5/ITPK1
t(14;14)(q32;q32)
  Adenocarcinoma Liver
TECPR2/WDR20
t(14;14)(q32;q32)
  Malignant epithelial tumor, special type Uterus, corpus
TRAF3/WDR20
t(14;14)(q32;q32)
  Embryonal nervous system tumor, special type Adrenal
TRAF3/ITPK1
t(14;14)(q32;q32)
  Transitional cell carcinoma Bladder
TRMT61A/AMN
t(14;14)(q32;q32)
  Astrocytoma, grade I-II Brain
UNC79/BRF1
t(14;14)(q32;q32)
  Adenocarcinoma Stomach
WDR20/DYNC1H1
t(14;14)(q32;q32)
  Adenocarcinoma Uterus, corpus
WDR20/PPP2R5C
t(14;14)(q32;q32)
  Squamous cell carcinoma Uterus, cervix
VRK1/PAPOLA
t(14;14)(q32;q32)

Kalyana-Sundaram et al 2012, Neoplasia
  Adenocarcinoma Breast
PAPOLA/AK7
t(14;14)(q32;q32)

Robinson et al 2011, Nat Med
  Adenocarcinoma Breast
PAPOLA/AK7
t(14;14)(q32;q32)

Wen et al 2012, PLoS One
  Acute myeloid leukemia, NOS
PLD4/AHNAK2
t(14;14)(q32;q32)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Ovary
RCOR1/PPP2R5C
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
ITPK1/CEP170B
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
MTA1/PACS2
t(14;14)(q32;q32)
  Squamous cell carcinoma Lung
MARK3/FBLN5
t(14;14)(q32;q32)
  Adenocarcinoma Lung
PAPOLA/AK7
t(14;14)(q32;q32)
  Adenocarcinoma Lung
SMEK1/FBLN5
t(14;14)(q32;q32)
  Adenocarcinoma Lung
GOLGA5/RIN3
t(14;14)(q32;q32)
  Adenocarcinoma Lung
ITPK1/BTBD7
t(14;14)(q32;q32)
  Adenocarcinoma Lung
YY1/CCNK
t(14;14)(q32;q32)
  Adenocarcinoma Lung
CATSPERB/TRIP11
t(14;14)(q32;q32)
  Astrocytoma, grade I-II Brain
UNC79/BRF1
t(14;14)(q32;q32)
  Astrocytoma, grade I-II Brain
EML1/FBLN5
t(14;14)(q32;q32)
  Squamous cell carcinoma Oral cavity
CDC42BPB/SMEK1
t(14;14)(q32;q32)
  Squamous cell carcinoma Oral cavity
TRAF3/CDC42BPB
t(14;14)(q32;q32)
  Squamous cell carcinoma Oral cavity
TTC7B/PPP2R5C
t(14;14)(q32;q32)
  Adenocarcinoma Breast
TRAF3/RCOR1
t(14;14)(q32;q32)
  Adenocarcinoma Breast
CATSPERB/FBLN5
t(14;14)(q32;q32)
  Adenocarcinoma Breast
CLMN/EVL
t(14;14)(q32;q32)
  Adenocarcinoma Breast
TC2N/FBLN5
t(14;14)(q32;q32)
  Adenocarcinoma Breast
CATSPERB/ATXN3
t(14;14)(q32;q32)
  Adenocarcinoma Breast
PPP1R13B/C14orf2
t(14;14)(q32;q32)
  Adenocarcinoma Breast
TC2N/TRIP11
t(14;14)(q32;q32)
  Adenocarcinoma Breast
EML1/CCNK
t(14;14)(q32;q32)
  Adenocarcinoma Breast
RPS6KA5/C14orf132
t(14;14)(q32;q32)
  Adenocarcinoma Breast
TRIP11/CYP46A1
t(14;14)(q32;q32)
  Adenocarcinoma Breast
UBR7/BTBD7
t(14;14)(q32;q32)
  Adenocarcinoma Breast
BTBD7/UBR7
t(14;14)(q32;q32)
  Adenocarcinoma Breast
CATSPERB/TC2N
t(14;14)(q32;q32)
  Adenocarcinoma Breast
EVL/EML1
t(14;14)(q32;q32)
  Adenocarcinoma Breast
PPP1R13B/CCDC88C
t(14;14)(q32;q32)
  Adenocarcinoma Breast
DYNC1H1/PPP2R5C
t(14;14)(q32;q32)
  Adenocarcinoma Breast
MARK3/BAG5
t(14;14)(q32;q32)
  Adenocarcinoma Breast
EFCAB11/ASB2
t(14;14)(q32;q32)
  Adenocarcinoma Breast
BRF1/FOXN3
t(14;14)(q32;q32)
  Adenocarcinoma Breast
CDC42BPB/UNC79
t(14;14)(q32;q32)
  Transitional cell carcinoma Bladder
RCOR1/TECPR2
t(14;14)(q32;q32)
  Transitional cell carcinoma Bladder
TTC7B/RPS6KA5
t(14;14)(q32;q32)

Zheng et al 2016, Cancer Cell
  Adenocarcinoma Adrenal
RCOR1/PPP2R5C
t(14;14)(q32;q32)